Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;27(12):1419-1429.
doi: 10.1111/jvh.13373. Epub 2020 Sep 14.

Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies

Abdullah Hamadeh  1 , Alex Haines  2 , Zeny Feng  3 , Hla-Hla Thein  2   4   5 , Naveed Z Janjua  6 , Murray Krahn  2   5 , William W L Wong  1   2   5
Affiliations

Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies

Abdullah Hamadeh et al. J Viral Hepat. 2020 Dec.

Abstract

Patients identified as having chronic hepatitis C (CHC) infection can be effectively and rapidly treated using direct-acting antiviral agents. However, there remains a substantial burden of subclinical undetected infection. This study estimates the prevalence and undiagnosed proportion of CHC in British Columbia (BC) and Ontario, Canada, using a model-based approach, informed by provincial population-level health administrative data. A two-step approach was used: Step 1) Two population-based retrospective analyses of administrative health data for a cohort of British Columbians and a cohort of Ontarians with CHC were conducted to generate population-level statistics of CHC-related health events; Step 2) using a validated natural history model of hepatitis C virus (HCV) infection, the historical prevalence of CHC was back-calculated from the data collected in Step 1. Our retrospective study found that, in BC and Ontario, the number of newly diagnosed CHC cases is declining yearly while the complications of the disease are increasing yearly. BC had a 2014 CHC prevalence of 1.04% (95% CI: 0.84%-1.44%), with 33.3% (95% CI: 25.5%-42.0%) of CHC cases undiagnosed. Ontario had a 2014 CHC prevalence of 0.91% (95% CI: 0.83%-1.02%) with 36.0% (95% CI: 31.2%-38.9%) of CHC cases undiagnosed. Our study offers robust estimates based on the integration of a validated natural history model with population-level health administrative data on HCV-related events, which can provide vital evidence for policymakers to develop appropriate policies to achieve elimination targets. Our approach can also be applied to produce robust region-specific estimates in other countries.

Keywords: chronic hepatitis C; mathematical modelling; population-level health administrative data; prevalence.

PubMed Disclaimer

References

REFERENCES

    1. Marshall AD, Saeed S, Barrett L, et al. Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ Open. 2016;4(4):E605-E614.
    1. Notice from the Executive Officer. Funding of Hepatitis C drug products under the Ontario Drug Benefit Program. Toronto, ON: Ontario Public Drug Programs; 2017.
    1. Wong WWL, Tu HA, Feld J, Wong T, Krahn M. Cost-effectiveness of screening for hepatitis C in Canada. Can Med Assoc J. 2015;187(3):E110-E121.
    1. Wong WWL, Erman A, Feld JJ, Krahn M. Model-based Projection of Health and Economic Effects of Screening for Hepatitis C Canada: Informing National Screening Recommendations. CMAJ Open. 2017;5(3):E662-E672.
    1. Wong WWL, Haines A, Zangneh H, Shah H. Can we afford not to screen and treat HCV infection in Canada. Can Liver J. 2018;1(2):51-65.

Publication types

Substances

LinkOut - more resources